The genetic background is currently under close scrutiny when determining cardiovascular disease progression and response to therapy. However, this factor is rarely considered in physiological studies, where it could influence the normal behaviour and adaptive responses of the heart. We aim to test the hypothesis that genetic strain variability is associated with differences in excitation-contraction coupling mechanisms, in particular those involved in cytoplasmic Ca 2+ regulation, and that they are concomitant to differences in whole-heart function and cell morphology.
Introduction
The genetic background is a well-recognized factor in determining disease progression and response to therapy, leading to the concept of personalized medicine. 1 In the cardiovascular field, the genetic background is clearly implicated in determining the pathophysiology of cardiomyopathies and arrhythmias. 2 -4 However, the genetic background is rarely considered in physiological studies, where it could influence the normal behaviour and adaptive responses. This factor is particularly important in studies using transgenic mice, where strain-specific physiological differences may influence the normal responses together with the susceptibility, the phenotype, and the progression of the disease under study.
Transgenic mouse technology has been instrumental for cardiovascular research, where significant advances have been made following the generation of the first cardioselective mouse line. 5 Transgenic mice have enabled identification of genetic, molecular, cellular, and physiological mechanisms involved in the pathogenesis of cardiac diseases such as hypertrophy, cardiomyopathy, heart failure, 6, 7 and arrhythmias. 8 -10 In physiological studies, transgenic mice have been used to define the function and regulation of several molecular mechanisms, including determinant elements of cardiac excitation-contraction (EC) coupling. 11 -13 There are several examples where studies performed using transgenic mice have generated unexpected results, allowing a novel assessment of the physiological function of ion transporters and receptors. 14, 15 In other cases, studies performed † These authors have contributed equally to this work.
using transgenic mice have generated controversy and discordant results. 16 One aspect that has been invoked or shown to affect the response, sometimes in opposite directions, is the background strain of the transgenic mouse colony. A study by Barrick et al., 17 for instance, showed that C57BL/6 mice develop a different form of cardiac hypertrophy compared with SV129 mice, when subjected to identical chronic aortic constriction. Similarly, genetically manipulating the secretion of growth factors in these two strains induces opposite pathophysiological responses. 18 The importance of the genetic background in mice should also be considered when studying physiological responses, but in the case of cardiac EC coupling, this has been only marginally investigated. Two early reports compared cell contraction and Ca 2+ transient morphology in C57BL/6 and FVB mice and showed significant differences between cardiac myocytes isolated from the two mouse strains. 19, 20 However, a more detailed investigation of the mechanisms involved in Ca 2+ regulation, and in particular of the sarcoplasmic reticulum (SR) Ca 2+ handling, was not performed. The correlation of these changes with cell morphology and whole heart function was not assessed.
In this study, we hypothesize that genetic strain variability is associated with differences in the function of Ca 2+ -handling mechanisms, in particular those involved in SR Ca 2+ regulation, and they are concomitant to differences in whole heart function and cell morphology. The C57BL/6 and FVB are the most commonly used mouse strains for transgenic and disease models, and together with the BALB/C and SV129 mouse strains, they account for up to 99% of strains used in cardiac research. For this reason, in these four different strains of mice-C57BL/6, BALB/C, FVB, and SV129-we compared: handling at the cellular level.
Methods

Animals
The protocol was approved by the Ethical Review Committee of the Heart Science Centre and by the UK Home Office under the terms of the Animals (Scientific Procedures) Act 1986 (which conforms with the NIH Guide for the Care and Use of Laboratory Animals (Publication No. 85-23, revised 1996); Assurance Number A5634-01). Four strains of mice were used for this study: C57BL/6, BALB/C, and SV129 (purchased from Harlan, Oxfordshire, UK) and FVB (purchased from Charles River, Kent, UK). All mice were 8-to 10-week-old males and were housed in an air-conditioned room with a 12 h light-dark cycle. The mice had access to standard mouse chow and tap water ad libitum.
Echocardiographic assessment of cardiac function
Mice were anaesthetized with 1.5% isoflurane. Transthoracic echocardiography was performed at a sweep speed of 100 mm/s using a 15 MHz linear transducer on an Acuson Sequioa TM 256 system (Siemens Medical, CA, USA). Parasternal short-axis views at the level of the midpapillary muscle enabled clear visualization of the heart. Images were obtained in a two-dimensional (2D) mode, allowing manual mapping of the circumferential systolic and diastolic left ventricular (LV) chamber area and enabling calculation of the 2D-mode LV ejection fraction (LVEF), and in M-mode for the calculation of the M-mode LVEF and LV fractional shortening (LVFS) (Figure 1 ).
Electrocardiographic measurements in conscious mice using radiotelemetry
Electrocardiograms (ECGs) were performed in conscious mice using a radiotelemetry system (Data Science International, St Paul, MN, USA), as described previously. 21 Mice were anaesthetized and a radiotelemetry transmitter (PhysioTel w model EA-F20, Data Science International) was implanted in the scruff of the neck, with the negative lead sutured in the muscle just under the right clavicle and the positive lead placed left of the xiphoid process. The mice were housed in individual cages for at least 5 days post-implantation before ECG recordings were obtained. Recordings were taken every 3 h, for a duration of 5 min each, over a 24 h period, during which the mice had access to food and water ad libitum and were exposed to a 12 h light -dark cycle. Analysis of the recording was performed using ECG-auto software (EMKA Technologies, Paris, France). The QT interval was corrected for heart rate (HR) variations using a method described previously. 21 
Myocyte isolation
Myocyte isolation was performed as described in Stagg et al. 21 Briefly, the ascending aorta was cannulated using a blunted 21 G needle, and the heart retrogradely perfused for 2 -3 min at 378C with normal containing protease (0.135 mg/mL; Sigma), followed by perfusion for 4 -7 min with ES containing collagenase (0.75 mg/mL; Worthington) and hyaluronidase (0.5 mg/mL; Sigma). The LV was then cut into fine pieces, resuspended in collagenase and hyaluronidase solution or ES alone, and agitated for further 4 -5 min in a water bath at 378C. Cells were then filtered through a 400 mm nylon mesh and centrifuged at 29.16 g for 1 min. The supernatant was discarded and the pellet of cells was resuspended and stored in ES at room temperature. Myocytes were used within 7 -8 h of isolation.
Myocyte and t-tubular morphology
Cardiomyocytes were incubated with 10 mM Di-8-ANEPPS (Molecular Probes, Eugene, OR, USA) for 10 min, then washed with ES. To visualize the t-tubule structure of cardiomyocytes, a z-series stack of images 1 mm apart was obtained with a confocal microscope (Zeiss LSM 510). During experiments, cells were perfused with NT solution at 378C. T-tubule density and cell volume analysis was performed using ImageJ software (NIH, USA, or http://rsbinfo.nih.gov/ij), as described previously. 22 
Sarcomere shortening measurements
Sarcomere shortening was measured using a computerized video-based edge-detection system (IonOptix Corporation, MA, USA). Cells were superfused with NT solution at 378C and field-stimulated using a pair of platinum electrodes connected to a MyoPacer TM stimulator (IonOptix Corporation). Cells were examined using a Nikon TE200 inverted microscope and ×60 objective lens, illuminated by a red light at a wavelength of .600 nm, directed to an intensified charge-coupled device camera (IonOptix Myocam CCD 100M). Cardiomyocyte images were acquired at 240 frames/s and a software (IonWizard, IonOptix Corporation) digitized sarcomere patterns by fast Fourier transformation into a frequency power spectrum. The criteria for selecting cardiomyocytes used in experiments included appropriate morphological appearance, resting sarcomere length .1.65 mm, and no spontaneous contractions when stimulated at 1 Hz.
All cells were initially field-stimulated at 1 Hz until steady-state contraction was reached. Cell shortening-frequency experiments were conducted on each cell at field stimulation frequencies of 2, 3, and 5 Hz.
Ca 21 transients and SR Ca 21 handling
The fluorescent indicator Indo-1 acetoxymethyl ester (AM) (Invitrogen) was used to monitor cytoplasmic Ca
2+
. Cells were loaded with 10 mM Indo-1 AM at room temperature in the dark for 20 min and then resuspended in ES for at least 1 h to allow de-esterification of the dye. Excitation wavelength was 385 nm, and after steady-state contractions were reached, the ratio of fluorescence emitted at 405 and 485 nm was collected and used as an indicator of intracellular [Ca 2+ ]. The ratio value was calculated after subtracting background fluorescence obtained from an empty field adjacent to the cell under investigation. 23 To allow the Genetic background and myocardial function quantitative assessment of [Ca 2+ ] within the cytoplasm, the calibration of the fluorescent signal inside the cell was performed using a method previously described by Grynkiewicz et 
Statistical analysis
Statistical comparison of data was performed using one-way analysis of variance followed by Bonferroni's post-test analysis. All statistical analyses were performed using Prism 4.0 (GraphPad Software Inc., USA), and P , 0.05 was considered to be significant. Data are expressed as mean + SEM (n) unless otherwise specified. N is the number of myocytes, from a minimum of four cell isolations per group.
Supplementary material
A Supplementary material file provides information on the measurements of electrophysiological and additional cell functional parameters.
Results
Strain comparison of cardiac function in vivo
Cardiac function in vivo was assessed using echocardiography ( Figure 1A) and ECG recordings. LVFS ( Figure 1B) and LVEF ( Figure 1C) were significantly higher in FVB mice compared with the other strains studied. Radiotelemetry was used to record ECGs of freely moving, conscious mice. Distinct P-waves and QRS complexes were present in ECG waveforms from all four strains ( Figure 2A ). FVB had a significantly higher HR ( Figure 2B ) with decrease in PR interval ( Figure 2C ). There was no significant difference in corrected QT interval ( Figure 2D ) between the four strains.
To investigate the diurnal variation in HR, ECG recordings were obtained every 3 h over a 24 h period ( Figure 2E ). BALB/C HR was the lowest at all times, whereas that of FVB was the highest. With the exception of FVB, there was a progressive diurnal decrease in HR and the lowest HRs were recorded at 12:00 h, when the FVB HR was significantly higher than other strains. FVB failed to show a distinct diurnal variation.
In summary, FVB mice showed significantly higher LVEF and LVFS with higher HR and lack of diurnal variations of HR compared with other strains.
Cardiomyocyte contractility and Ca
handling
Cardiomyocyte contractility was assessed by measuring real-time changes in sarcomere length when stimulating at 1, 2, 3, and 5 Hz. Cardiomyocytes from all four mice strains exhibited a negative sarcomere shortening-frequency relationship (for 2, 3, and 5 Hz P , 0.01 vs. 1 Hz) ( Figure 3A ; see Supplementary material online, Figure S1A and B). At 3 Hz field stimulation, BALB/C myocyte sarcomere shortening (0.022 + 0.002 mm, n ¼ 27) was significantly smaller than that of C57BL/6 myocytes (0.040 + 0.004 mm, n ¼ 59, P , 0.05). Increasing the stimulation frequency resulted in faster relaxation to 50% sarcomere length in myocytes from all four strains. However, BALB/C had a prolonged time to 50% relaxation at all frequencies compared with the other three strains ( Figure 3B ).
There were no significant strain differences in diastolic [Ca 2+ ] with the exception of C57BL/6 cardiomyocytes, which had significantly higher diastolic [Ca 2+ ] compared with SV129 at 2 and 3 Hz and lower compared with FVB at 5 Hz (see Supplementary material online, Figure S1C ). transients from different strains are shown in Figure 3C . There were no significant strain differences in Ca Genetic background and myocardial function increasing frequency (see Supplementary material online, Figure S1D ). When comparing the four strains, time-to-peak of the Ca 2+ transient was prolonged in BALB/C by 34, 50, and 60% relative to C57BL/6, FVB, and SV129, respectively. In addition, C57BL/6 Ca 2+ transient time-to-peak was significantly longer compared with SV129 ( Figure 3E ). There was no difference in time-to-90% transient decay at 1, 2, 3, and 5 Hz ( Figure 3F ). The Ca 2+ transient decay time constant t was higher in FVB cardiomyocytes when compared with SV129 at 2 Hz and C57BL/6 and SV129 at 3 Hz (see Supplementary material online, Figure S1E ). Figure 4A ). There were no significant strain differences in SR fractional release ( Figure 4B ). The two major mechanisms involved in Ca 2+ extrusion, SR Ca 2+ uptake and NCX, were also investigated.
NCX contribution to Ca 2+ extrusion was determined by the time constant t, calculated by fitting a mono-exponential curve to the decay phase of the caffeine-induced Ca 2+ transient. NCX contribution ranged between 7 and 15%, and there was no significant difference between the four strains ( Figure 4C ). SERCA contribution to Ca 2+ extrusion was assessed by calculating the difference between caffeine-induced transient decay t and 1 Hz field-stimulated transient decay t.
26 SERCA contribution ranged between 85 and 92%, and there were no significant strain differences ( Figure 4D ). Ca 2+ sparks are spontaneous release of Ca 2+ from an RyR cluster during rest. Their frequency was significantly increased in BALB/C myocytes compared with FVB myocytes ( Figure 5A ). Further analysis revealed that Ca 2+ sparks in C57BL/6 and BALB/C myocytes had prolonged duration ( Figure 5D ) compared with FVB, but there was no difference in sparks amplitude ( Figure 5B ) or width ( Figure 5C ) between strains. SR Ca 2+ leak, calculated as the product of spark frequency, mean amplitude, mean width, and mean duration, was significantly elevated in BALB/C compared with FVB and SV129 ( Figure 5E ). as NCX. We measured action potentials and L-type Ca 2+ current in the four strains but no differences could be detected (see Supplementary material online, Figure S2 and Table S1 ).
Strain comparison of cardiomyocyte morphology
Myocyte volume was assessed using confocal microscopy. SV129 cardiac myocytes had a significantly smaller volume compared with Genetic background and myocardial function myocytes from C57BL/6, BALB/C, and FVB ( Figure 6A ). Further, t-tubule density was measured as this parameter has been associated with changes in EC coupling. 28 T-tubule density was significantly decreased in SV129 myocytes ( Figure 6B ).
Discussion
In this study, we have identified distinct features of structural and functional cardiac parameters in different strains of mice. First, we have shown that parameters of heart function in vivo, such as LVFS and LVEF, are higher in FVB than in other mouse strains. These findings are associated with higher HR and lack of diurnal variation of HR. At the myocyte functional level, both sarcomere relaxation and time- handling, possibly having an influence on the physiological response, on the phenotype of the disease under investigation, and on the response to therapy. More experiments are required to identify the nature of the genetic differences that are responsible for these changes.
In vivo cardiac function
Functional parameters such as LVEF and LVFS are higher in FVB mice. These findings may indicate a more effective contractility. However, changes in vascular resistance in this strain could explain the observed variations in LVEF and LVFS. Blood pressure was not measured here and further studies are required to clarify this point. The echocardiographic studies were performed in anaesthetized animals and it is difficult to determine the relevance of these findings during exercise, stress, or disease.
Given that LVEF and FS are often used as indication for dysfunction in animal models of disease, our findings further highlight the need to better define normality and to consider genetic variability in animal studies.
Our results also show that FVB do not exhibit a diurnal variation in HR. C57BL/6, BALB/C, and SV129 mice HRs are significantly lower in the light periods, indicating a circadian rhythm, that may potentially be mediated by the intracellular circadian clock within the cardiomyocyte and/or extracellular neurohormonal influences. 29 The circadian clock can regulate electrical activity, calcium homeostasis, contractile protein composition, and myocyte metabolism. 29 Our results also show that FVB have a significantly faster HR ( Figure 2B ). This is consistent with findings by Shusterman et al., 30 who have shown strain-specific differences in autonomic nervous system activity, which together with the cardiomyocyte circadian clock could account for the strain-specific differences observed in HR and diurnal variation in HR.
Interstrain comparison of EC coupling and Ca 21 handling
Results shown in Figure 3E indicate a prolonged duration of the time- 32 Our results show that C57BL/6 and BALB/C myocytes have a significantly higher t-tubule density ( Figure 6B ). Ca 2+ sparks were more frequent in BALB/C myocytes only, but in both C57BL/6 and BALB/C, Ca 2+ sparks lasted longer compared with Ca 2+ sparks from other strains ( Figure 5A and D) .
However, the SR Ca 2+ leak was significantly higher only in BALB/C ( Figure 5E ). One possible reason to explain the increased SR Ca 2+ leak in this strain is that the high t-tubule density would harbour more L-type Ca 2+ channels, therefore increasing the probability of This is a feature of normal cardiac muscle and is disrupted in cardiac disease. 33 In our study, the synchronicity of Ca 2+ release was unchanged suggesting that local disruption of CICR is not responsible for the effects observed. Strain differences in phosphorylation of the RyR by protein kinase A or Ca 2+ /calmodulin-dependent protein kinase (CaMKII) 34 can also explain our results and more studies are required to investigate the specific mechanisms involved in the observed differences in EC coupling among strains.
Another unclear aspect of this study is the discrepancy between the reduction of amplitude in sarcomere shortening and Ca 2+ transients at different frequencies, suggesting that myofilament sensitivity to Ca 2+ is different in the four strains studied. Future studies should address this aspect which may be an important determinant of strain differences in heart and cardiomyocyte function.
Relevance to cardiovascular research
To our knowledge, this is the first study to directly compare cardiac function in vivo and functional/structural properties of isolated ventricular myocytes in four different strains of mice. Shusterman et al. 30 have shown interstrain differences in survival of mice with congestive heart failure, whereas Suzuki et al. 35 observed strain variation in the cardiac function and survival of cardiac-specific calsequestrin-overexpressing mice. Single-nucleotide base substitutions (SNPs) at a certain gene or genomic position represent the major part of inter-individual variability. The comprehensive sequencing of the human genome has unveiled the magnitude of natural genetic variance within the human population. 36 Common genetic variants have been shown to increase the risk of cardiac arrhythmias, and most recent studies show that even SNPs can alter cardiac electrical manifestations in certain populations. 36 Genetic variation also influences the response to drug therapy. For example, the level or function of key mediators of heart failure pathogenesis can be altered by genetic background, and this variation can be used to predict drug response and target therapeutics. 37 Pharmacogenomics holds the promise for more individualized therapies that maximize patient benefits and minimize risks. 38 In this study, we have demonstrated that genetic variation is associated with strain-specific physiological differences in cardiac function in vivo and differences in contractility and Ca 2+ handling at the cellular level. This should be considered in studies involving transgenic technology and is relevant for the assessment of the individual physiological parameters, susceptibility to disease, and response to therapy.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
